Schedule 13D ownership disclosure

ESSA PHARMA INC

Security class unavailable · CUSIP: 29668H104

Event date: 2022-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-007708
Form type
SC 13D/A
Filer
Clarus Lifesciences III, L.P.
CIK
CIK 1597143
Filed
Jan 12, 2022
Reporting period
Jan 10, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub